We are live on ! Find out more
DMK

David M. Knott Portfolio holdings

AUM $275M
1-Year Est. Return 59.23%
This Fund
S&P 500
This Quarter Est. Return
+7.86%
1 Year Est. Return
+59.23%
3 Year Est. Return
+80.95%
5 Year Est. Return
+223.18%
10 Year Est. Return
–
AUM
$234M
AUM Growth
-$5.63M
Cap. Flow
-$22.7M
Cap. Flow %
-9.71%
Top 10 Hldgs %
77.03%
Holding
114
New
24
Increased
15
Reduced
9
Closed
6

Top Buys

Rank Stock Value
1
DD icon
DuPont de Nemours
DD
+$1.24M
2
ATCO
Atlas Corp.
ATCO
+$963K
3
XRN.PRA
Chiron Real Estate Inc Series A Preferred Stock
XRN.PRA
+$871K
4
KMB icon
Kimberly-Clark
KMB
+$733K
5
RXDX
Ignyta, Inc.
RXDX
+$698K

Top Sells

Rank Stock Value
1
LGND icon
Ligand Pharmaceuticals
LGND
+$25.4M
2
AGN
Allergan plc
AGN
+$2.3M
3
PFE icon
Pfizer
PFE
+$1.93M
4
ABBV icon
AbbVie
ABBV
+$1.35M
5
DD
Du Pont De Nemours E I
DD
+$1.19M

Sector Composition

Rank Sector Weight
1 Healthcare 70.52%
2 Financials 8.46%
3 Technology 4.11%
4 Real Estate 3.89%
5 Industrials 3.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IMMU
26
DELISTED
Immunomedics Inc
IMMU
$915K 0.39%
65,483
-300
-0.5% -$2.99K
VZ icon
27
Verizon
VZ
$208B
$906K 0.39%
18,311
– –
APO icon
28
Apollo Global Management
APO
$79.7B
$903K 0.39%
30,000
– –
MIC
29
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
$888K 0.38%
12,300
– –
XRN.PRA
30
Chiron Real Estate Inc Series A Preferred Stock
XRN.PRA
$78.1M
$878K 0.38%
+35,000
New +$871K
FF icon
31
Future Fuel
FF
$234M
$863K 0.37%
54,804
– –
T icon
32
AT&T
T
$178B
$863K 0.37%
29,194
– –
GILD icon
33
Gilead Sciences
GILD
$181B
$844K 0.36%
10,420
– –
RXDX
34
DELISTED
Ignyta, Inc.
RXDX
$836K 0.36%
+67,700
New +$698K
STML
35
DELISTED
Stemline Therapeutics, Inc.
STML
$832K 0.36%
74,992
+33,300
+80% +$313K
RHP icon
36
Ryman Hospitality Properties
RHP
$8.92B
$775K 0.33%
12,400
– –
NVLN
37
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
$768K 0.33%
109,184
– –
GBT
38
DELISTED
Global Blood Therapeutics, Inc.
GBT
$752K 0.32%
24,224
+11,500
+90% +$323K
SVC
39
Service Properties Trust
SVC
$1.02B
$712K 0.3%
5,000
– –
KMB icon
40
Kimberly-Clark
KMB
$36.4B
$706K 0.3%
+6,000
New +$733K
GE icon
41
GE Aerospace
GE
$355B
$693K 0.3%
5,984
– –
XRN
42
Chiron Real Estate Inc
XRN
$487M
$691K 0.3%
15,400
– –
WY icon
43
Weyerhaeuser
WY
$17B
$681K 0.29%
20,000
– –
WHLRD
44
Wheeler Real Estate Investment Trust Series D Preferred Stock
WHLRD
$64.9M
$680K 0.29%
30,000
– –
CNCE
45
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$664K 0.28%
+45,000
New +$653K
BLCM
46
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$658K 0.28%
5,698
+3,700
+185% +$389K
DERM
47
DELISTED
Dermira, Inc.
DERM
$649K 0.28%
24,036
+5,605
+30% +$147K
MDLZ icon
48
Mondelez International
MDLZ
$79.6B
$647K 0.28%
15,900
+10,000
+169% +$425K
SBCP
49
DELISTED
Sunshine Bancorp, Inc
SBCP
$646K 0.28%
27,800
– –
IBM icon
50
IBM
IBM
$222B
$622K 0.27%
4,481
– –
1
2
3 4 5

Similar funds

FA
FMA Advisory Harrisburg, Pennsylvania $268M AUM 30.8% 1-Year Est. Return
KCP
KDI Capital Partners Raleigh, North Carolina $290M AUM 26.07% 1-Year Est. Return
HCIA
Hochman Cole Investment Advisors Deerfield, Illinois $255M AUM 23.27% 1-Year Est. Return
ISG
Investment Security Group Denver, Colorado $252M AUM 28.26% 1-Year Est. Return
TPCM
Three Peaks Capital Management Castle Rock, Colorado $301M AUM 43.39% 1-Year Est. Return
DCM
DeGreen Capital Management Scottsdale, Arizona $301M AUM 17.24% 1-Year Est. Return
MCL
MIK Capital LP New York $247M AUM 78.02% 1-Year Est. Return
DVC
Deer VII & Co Larchmont, New York $317M AUM 30.89% 1-Year Est. Return

David M. Knott's Q3 2017 Portfolio in Review

As of Q3 2017, David M. Knott held 114 positions worth $234M, down 2.4% from $240M the previous quarter. Its ten largest holdings account for 77% of the portfolio.

David M. Knott withdrew a net $22.7M in Q3 2017, closing 6 positions and reducing 9 holdings. Its most notable exit was Allergan plc, an estimated $2.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 71% of assets, down from 73% a quarter earlier, followed by Financials and Technology.

Against the trend, David M. Knott opened a new position in Atlas Corp. worth $993K.

  • David M. Knott's largest Q3 2017 buy was Atlas Corp.: 140,000 shares worth $993K.
  • David M. Knott added most to DuPont de Nemours in Q3 2017, an estimated $1.24M increase.
  • David M. Knott's biggest Q3 2017 reduction was Ligand Pharmaceuticals, cutting an estimated $25.4M.
  • David M. Knott fully exited Allergan plc in Q3 2017, selling an estimated $2.3M.
  • David M. Knott's ten largest holdings make up 77% of its $234M portfolio in Q3 2017.
  • David M. Knott opened 24 new positions and closed 6 in Q3 2017.
  • David M. Knott's portfolio value fell 2.4% quarter-over-quarter to $234M.

Based on David M. Knott's 13F filing for Q3 2017, filed 13 Nov 2017.